nodes	percent_of_prediction	percent_of_DWPC	metapath
Mycophenolate mofetil—CYP3A4—bone cancer	0.263	1	CbGaD
Mycophenolate mofetil—UGT2B7—Epirubicin—bone cancer	0.0899	0.194	CbGbCtD
Mycophenolate mofetil—SLCO1B3—Methotrexate—bone cancer	0.0475	0.103	CbGbCtD
Mycophenolate mofetil—ABCC2—Carboplatin—bone cancer	0.0438	0.0948	CbGbCtD
Mycophenolate mofetil—ABCG2—Carboplatin—bone cancer	0.0396	0.0857	CbGbCtD
Mycophenolate mofetil—ABCC2—Cisplatin—bone cancer	0.0375	0.081	CbGbCtD
Mycophenolate mofetil—ABCG2—Cisplatin—bone cancer	0.0339	0.0733	CbGbCtD
Mycophenolate mofetil—SLCO1B1—Methotrexate—bone cancer	0.0277	0.0599	CbGbCtD
Mycophenolate mofetil—ABCC2—Doxorubicin—bone cancer	0.0251	0.0543	CbGbCtD
Mycophenolate mofetil—ABCC2—Methotrexate—bone cancer	0.0243	0.0526	CbGbCtD
Mycophenolate mofetil—ABCG2—Doxorubicin—bone cancer	0.0227	0.0491	CbGbCtD
Mycophenolate mofetil—ABCG2—Methotrexate—bone cancer	0.022	0.0476	CbGbCtD
Mycophenolate mofetil—ALB—Methotrexate—bone cancer	0.0152	0.0328	CbGbCtD
Mycophenolate mofetil—ABCB1—Cisplatin—bone cancer	0.0122	0.0264	CbGbCtD
Mycophenolate mofetil—ABCB1—Doxorubicin—bone cancer	0.00819	0.0177	CbGbCtD
Mycophenolate mofetil—ABCB1—Methotrexate—bone cancer	0.00793	0.0171	CbGbCtD
Mycophenolate mofetil—CYP3A4—Doxorubicin—bone cancer	0.0049	0.0106	CbGbCtD
Mycophenolate mofetil—CYP3A5—Tamoxifen metabolism—CYP3A4—bone cancer	0.000384	0.00404	CbGpPWpGaD
Mycophenolate mofetil—UGT1A8—Biological oxidations—CYP3A4—bone cancer	0.000363	0.00382	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I2—bone cancer	0.000362	0.00381	CbGpPWpGaD
Mycophenolate mofetil—UGT1A10—Metapathway biotransformation—GSTP1—bone cancer	0.00036	0.00379	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metapathway biotransformation—CYP4V2—bone cancer	0.000356	0.00375	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Xenobiotics—CYP3A4—bone cancer	0.000346	0.00364	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Drug Induction of Bile Acid Pathway—CYP3A4—bone cancer	0.000343	0.00361	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.000337	0.00355	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Tamoxifen metabolism—CYP3A4—bone cancer	0.000333	0.0035	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—PPAR Alpha Pathway—CDK4—bone cancer	0.00033	0.00347	CbGpPWpGaD
Mycophenolate mofetil—CES1—E2F transcription factor network—PLAU—bone cancer	0.000328	0.00345	CbGpPWpGaD
Mycophenolate mofetil—IMPDH2—Metabolism—NDUFA12—bone cancer	0.000314	0.0033	CbGpPWpGaD
Mycophenolate mofetil—UGT1A8—Biological oxidations—GSTP1—bone cancer	0.00031	0.00327	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metapathway biotransformation—CYP4V2—bone cancer	0.000308	0.00324	CbGpPWpGaD
Mycophenolate mofetil—UGT1A6—Aryl Hydrocarbon Receptor Pathway—JUN—bone cancer	0.000304	0.0032	CbGpPWpGaD
Mycophenolate mofetil—UGT1A7—Metabolism—NDUFA12—bone cancer	0.00028	0.00294	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.000274	0.00288	CbGpPWpGaD
Mycophenolate mofetil—CES1—E2F transcription factor network—RB1—bone cancer	0.000269	0.00283	CbGpPWpGaD
Mycophenolate mofetil—UGT1A6—Biological oxidations—CYP3A4—bone cancer	0.000265	0.00279	CbGpPWpGaD
Mycophenolate mofetil—UGT1A6—Metapathway biotransformation—CYP3A4—bone cancer	0.000261	0.00275	CbGpPWpGaD
Mycophenolate mofetil—IMPDH2—Metabolism—NT5C3A—bone cancer	0.00026	0.00274	CbGpPWpGaD
Mycophenolate mofetil—UGT1A6—NRF2 pathway—TGFBR2—bone cancer	0.000258	0.00272	CbGpPWpGaD
Mycophenolate mofetil—UGT1A6—NRF2 pathway—GSTP1—bone cancer	0.000258	0.00272	CbGpPWpGaD
Mycophenolate mofetil—IMPDH1—Metabolism—NDUFA12—bone cancer	0.000256	0.00269	CbGpPWpGaD
Mycophenolate mofetil—CES1—Fluoropyrimidine Activity—TP53—bone cancer	0.000249	0.00262	CbGpPWpGaD
Mycophenolate mofetil—CES1—NRF2 pathway—TGFBR2—bone cancer	0.000245	0.00258	CbGpPWpGaD
Mycophenolate mofetil—CES1—NRF2 pathway—GSTP1—bone cancer	0.000245	0.00258	CbGpPWpGaD
Mycophenolate mofetil—UGT1A6—Aryl Hydrocarbon Receptor Pathway—EGFR—bone cancer	0.000239	0.00251	CbGpPWpGaD
Mycophenolate mofetil—ALB—Binding and Uptake of Ligands by Scavenger Receptors—SPARC—bone cancer	0.000234	0.00246	CbGpPWpGaD
Mycophenolate mofetil—UGT1A7—Metabolism—NT5C3A—bone cancer	0.000232	0.00244	CbGpPWpGaD
Mycophenolate mofetil—UGT1A6—Biological oxidations—GSTP1—bone cancer	0.000226	0.00238	CbGpPWpGaD
Mycophenolate mofetil—UGT1A6—Metapathway biotransformation—GSTP1—bone cancer	0.000223	0.00235	CbGpPWpGaD
Mycophenolate mofetil—UGT1A8—Metabolism—NDUFA12—bone cancer	0.000218	0.00229	CbGpPWpGaD
Mycophenolate mofetil—IMPDH1—Metabolism—NT5C3A—bone cancer	0.000212	0.00223	CbGpPWpGaD
Mycophenolate mofetil—UGT2B7—Phase II conjugation—GSTP1—bone cancer	0.000211	0.00222	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.000208	0.00219	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.000207	0.00218	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.000197	0.00207	CbGpPWpGaD
Mycophenolate mofetil—UGT1A8—Metabolism—NT5C3A—bone cancer	0.00018	0.0019	CbGpPWpGaD
Mycophenolate mofetil—UGT1A1—Phase II conjugation—GSTP1—bone cancer	0.000172	0.00181	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Phase II conjugation—GSTP1—bone cancer	0.000172	0.00181	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000166	0.00174	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metapathway biotransformation—CYP4V2—bone cancer	0.000166	0.00174	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000164	0.00172	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—bone cancer	0.000159	0.00167	CbGpPWpGaD
Mycophenolate mofetil—UGT1A6—Metabolism—NDUFA12—bone cancer	0.000159	0.00167	CbGpPWpGaD
Mycophenolate mofetil—ALB—Folate Metabolism—DHFR—bone cancer	0.000156	0.00164	CbGpPWpGaD
Mycophenolate mofetil—UGT2B7—Biological oxidations—CYP3A4—bone cancer	0.000145	0.00152	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000144	0.00151	CbGpPWpGaD
Mycophenolate mofetil—UGT2B7—Metapathway biotransformation—CYP3A4—bone cancer	0.000143	0.0015	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000142	0.00149	CbGpPWpGaD
Mycophenolate mofetil—UGT2B7—NRF2 pathway—GSTP1—bone cancer	0.000141	0.00148	CbGpPWpGaD
Mycophenolate mofetil—UGT2B7—NRF2 pathway—TGFBR2—bone cancer	0.000141	0.00148	CbGpPWpGaD
Mycophenolate mofetil—ALB—Platelet degranulation—SPARC—bone cancer	0.000137	0.00144	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Aryl Hydrocarbon Receptor Pathway—JUN—bone cancer	0.000135	0.00142	CbGpPWpGaD
Mycophenolate mofetil—UGT1A1—Aryl Hydrocarbon Receptor Pathway—JUN—bone cancer	0.000135	0.00142	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000134	0.00141	CbGpPWpGaD
Mycophenolate mofetil—UGT1A6—Metabolism—NT5C3A—bone cancer	0.000132	0.00138	CbGpPWpGaD
Mycophenolate mofetil—ALB—Response to elevated platelet cytosolic Ca2+—SPARC—bone cancer	0.00013	0.00137	CbGpPWpGaD
Mycophenolate mofetil—UGT2B7—Biological oxidations—GSTP1—bone cancer	0.000124	0.0013	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B3—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000123	0.00129	CbGpPWpGaD
Mycophenolate mofetil—UGT2B7—Metapathway biotransformation—GSTP1—bone cancer	0.000122	0.00128	CbGpPWpGaD
Mycophenolate mofetil—UGT1A1—Biological oxidations—CYP3A4—bone cancer	0.000117	0.00124	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Biological oxidations—CYP3A4—bone cancer	0.000117	0.00124	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000116	0.00122	CbGpPWpGaD
Mycophenolate mofetil—UGT1A1—Metapathway biotransformation—CYP3A4—bone cancer	0.000116	0.00122	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metapathway biotransformation—CYP3A4—bone cancer	0.000116	0.00122	CbGpPWpGaD
Mycophenolate mofetil—UGT1A1—NRF2 pathway—GSTP1—bone cancer	0.000115	0.0012	CbGpPWpGaD
Mycophenolate mofetil—UGT1A1—NRF2 pathway—TGFBR2—bone cancer	0.000115	0.0012	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—NRF2 pathway—GSTP1—bone cancer	0.000115	0.0012	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—NRF2 pathway—TGFBR2—bone cancer	0.000115	0.0012	CbGpPWpGaD
Mycophenolate mofetil—IMPDH2—Metabolism—ENO2—bone cancer	0.000114	0.0012	CbGpPWpGaD
Mycophenolate mofetil—ABCC2—NRF2 pathway—GSTP1—bone cancer	0.000112	0.00118	CbGpPWpGaD
Mycophenolate mofetil—ABCC2—NRF2 pathway—TGFBR2—bone cancer	0.000112	0.00118	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B3—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000106	0.00112	CbGpPWpGaD
Mycophenolate mofetil—UGT1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—bone cancer	0.000106	0.00111	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Aryl Hydrocarbon Receptor Pathway—EGFR—bone cancer	0.000106	0.00111	CbGpPWpGaD
Mycophenolate mofetil—IMPDH2—Metabolism—DHFR—bone cancer	0.000106	0.00111	CbGpPWpGaD
Mycophenolate mofetil—UGT1A7—Metabolism—ENO2—bone cancer	0.000102	0.00107	CbGpPWpGaD
Mycophenolate mofetil—Sinusitis—Epirubicin—bone cancer	0.000101	0.000559	CcSEcCtD
Mycophenolate mofetil—UGT1A1—Biological oxidations—GSTP1—bone cancer	0.0001	0.00106	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Biological oxidations—GSTP1—bone cancer	0.0001	0.00106	CbGpPWpGaD
Mycophenolate mofetil—Hyperglycaemia—Doxorubicin—bone cancer	0.0001	0.000558	CcSEcCtD
Mycophenolate mofetil—Agranulocytosis—Epirubicin—bone cancer	0.0001	0.000556	CcSEcCtD
Mycophenolate mofetil—Pneumonia—Doxorubicin—bone cancer	9.98e-05	0.000554	CcSEcCtD
Mycophenolate mofetil—Infestation—Doxorubicin—bone cancer	9.92e-05	0.000551	CcSEcCtD
Mycophenolate mofetil—Infestation NOS—Doxorubicin—bone cancer	9.92e-05	0.000551	CcSEcCtD
Mycophenolate mofetil—Visual impairment—Methotrexate—bone cancer	9.91e-05	0.000551	CcSEcCtD
Mycophenolate mofetil—UGT1A1—Metapathway biotransformation—GSTP1—bone cancer	9.91e-05	0.00104	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metapathway biotransformation—GSTP1—bone cancer	9.91e-05	0.00104	CbGpPWpGaD
Mycophenolate mofetil—IMPDH2—Metabolism—GNA11—bone cancer	9.88e-05	0.00104	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Fluoropyrimidine Activity—TP53—bone cancer	9.84e-05	0.00104	CbGpPWpGaD
Mycophenolate mofetil—Hypersensitivity—Cisplatin—bone cancer	9.81e-05	0.000545	CcSEcCtD
Mycophenolate mofetil—Bradycardia—Epirubicin—bone cancer	9.8e-05	0.000544	CcSEcCtD
Mycophenolate mofetil—Renal failure—Doxorubicin—bone cancer	9.75e-05	0.000542	CcSEcCtD
Mycophenolate mofetil—Neuropathy peripheral—Doxorubicin—bone cancer	9.73e-05	0.00054	CcSEcCtD
Mycophenolate mofetil—Haemoglobin—Epirubicin—bone cancer	9.68e-05	0.000537	CcSEcCtD
Mycophenolate mofetil—Stomatitis—Doxorubicin—bone cancer	9.67e-05	0.000537	CcSEcCtD
Mycophenolate mofetil—Jaundice—Doxorubicin—bone cancer	9.67e-05	0.000537	CcSEcCtD
Mycophenolate mofetil—Rhinitis—Epirubicin—bone cancer	9.65e-05	0.000536	CcSEcCtD
Mycophenolate mofetil—Urinary tract infection—Doxorubicin—bone cancer	9.65e-05	0.000536	CcSEcCtD
Mycophenolate mofetil—Conjunctivitis—Doxorubicin—bone cancer	9.65e-05	0.000536	CcSEcCtD
Mycophenolate mofetil—Haemorrhage—Epirubicin—bone cancer	9.63e-05	0.000535	CcSEcCtD
Mycophenolate mofetil—Hepatitis—Epirubicin—bone cancer	9.63e-05	0.000535	CcSEcCtD
Mycophenolate mofetil—Eye disorder—Methotrexate—bone cancer	9.61e-05	0.000534	CcSEcCtD
Mycophenolate mofetil—SLCO1B3—Metabolism—NDUFA12—bone cancer	9.6e-05	0.00101	CbGpPWpGaD
Mycophenolate mofetil—Tinnitus—Methotrexate—bone cancer	9.59e-05	0.000533	CcSEcCtD
Mycophenolate mofetil—Hypoaesthesia—Epirubicin—bone cancer	9.58e-05	0.000532	CcSEcCtD
Mycophenolate mofetil—Asthenia—Cisplatin—bone cancer	9.56e-05	0.000531	CcSEcCtD
Mycophenolate mofetil—Pharyngitis—Epirubicin—bone cancer	9.56e-05	0.000531	CcSEcCtD
Mycophenolate mofetil—Cardiac disorder—Methotrexate—bone cancer	9.55e-05	0.00053	CcSEcCtD
Mycophenolate mofetil—Sweating—Doxorubicin—bone cancer	9.51e-05	0.000528	CcSEcCtD
Mycophenolate mofetil—Urinary tract disorder—Epirubicin—bone cancer	9.51e-05	0.000528	CcSEcCtD
Mycophenolate mofetil—Oedema peripheral—Epirubicin—bone cancer	9.48e-05	0.000527	CcSEcCtD
Mycophenolate mofetil—Haematuria—Doxorubicin—bone cancer	9.46e-05	0.000526	CcSEcCtD
Mycophenolate mofetil—Connective tissue disorder—Epirubicin—bone cancer	9.46e-05	0.000526	CcSEcCtD
Mycophenolate mofetil—Urethral disorder—Epirubicin—bone cancer	9.44e-05	0.000524	CcSEcCtD
Mycophenolate mofetil—UGT1A7—Metabolism—DHFR—bone cancer	9.42e-05	0.000991	CbGpPWpGaD
Mycophenolate mofetil—Hepatobiliary disease—Doxorubicin—bone cancer	9.38e-05	0.000521	CcSEcCtD
Mycophenolate mofetil—Epistaxis—Doxorubicin—bone cancer	9.36e-05	0.00052	CcSEcCtD
Mycophenolate mofetil—Angiopathy—Methotrexate—bone cancer	9.33e-05	0.000518	CcSEcCtD
Mycophenolate mofetil—Sinusitis—Doxorubicin—bone cancer	9.31e-05	0.000517	CcSEcCtD
Mycophenolate mofetil—IMPDH1—Metabolism—ENO2—bone cancer	9.29e-05	0.000977	CbGpPWpGaD
Mycophenolate mofetil—Visual impairment—Epirubicin—bone cancer	9.28e-05	0.000515	CcSEcCtD
Mycophenolate mofetil—Mediastinal disorder—Methotrexate—bone cancer	9.27e-05	0.000515	CcSEcCtD
Mycophenolate mofetil—Agranulocytosis—Doxorubicin—bone cancer	9.26e-05	0.000514	CcSEcCtD
Mycophenolate mofetil—Chills—Methotrexate—bone cancer	9.23e-05	0.000513	CcSEcCtD
Mycophenolate mofetil—Diarrhoea—Cisplatin—bone cancer	9.11e-05	0.000506	CcSEcCtD
Mycophenolate mofetil—Alopecia—Methotrexate—bone cancer	9.09e-05	0.000505	CcSEcCtD
Mycophenolate mofetil—Bradycardia—Doxorubicin—bone cancer	9.07e-05	0.000504	CcSEcCtD
Mycophenolate mofetil—Mental disorder—Methotrexate—bone cancer	9.01e-05	0.000501	CcSEcCtD
Mycophenolate mofetil—Eye disorder—Epirubicin—bone cancer	9e-05	0.0005	CcSEcCtD
Mycophenolate mofetil—Tinnitus—Epirubicin—bone cancer	8.98e-05	0.000499	CcSEcCtD
Mycophenolate mofetil—IMPDH2—Metabolism—CYP3A4—bone cancer	8.96e-05	0.000942	CbGpPWpGaD
Mycophenolate mofetil—Malnutrition—Methotrexate—bone cancer	8.96e-05	0.000497	CcSEcCtD
Mycophenolate mofetil—Haemoglobin—Doxorubicin—bone cancer	8.95e-05	0.000497	CcSEcCtD
Mycophenolate mofetil—Cardiac disorder—Epirubicin—bone cancer	8.94e-05	0.000496	CcSEcCtD
Mycophenolate mofetil—Rhinitis—Doxorubicin—bone cancer	8.93e-05	0.000496	CcSEcCtD
Mycophenolate mofetil—Haemorrhage—Doxorubicin—bone cancer	8.91e-05	0.000495	CcSEcCtD
Mycophenolate mofetil—Hepatitis—Doxorubicin—bone cancer	8.91e-05	0.000495	CcSEcCtD
Mycophenolate mofetil—Hypoaesthesia—Doxorubicin—bone cancer	8.86e-05	0.000492	CcSEcCtD
Mycophenolate mofetil—Pharyngitis—Doxorubicin—bone cancer	8.84e-05	0.000491	CcSEcCtD
Mycophenolate mofetil—UGT1A7—Metabolism—GNA11—bone cancer	8.81e-05	0.000926	CbGpPWpGaD
Mycophenolate mofetil—Urinary tract disorder—Doxorubicin—bone cancer	8.8e-05	0.000489	CcSEcCtD
Mycophenolate mofetil—ABCC2—Transmembrane transport of small molecules—TUBB4B—bone cancer	8.78e-05	0.000924	CbGpPWpGaD
Mycophenolate mofetil—Oedema peripheral—Doxorubicin—bone cancer	8.78e-05	0.000487	CcSEcCtD
Mycophenolate mofetil—Dysgeusia—Methotrexate—bone cancer	8.77e-05	0.000487	CcSEcCtD
Mycophenolate mofetil—Connective tissue disorder—Doxorubicin—bone cancer	8.75e-05	0.000486	CcSEcCtD
Mycophenolate mofetil—Angiopathy—Epirubicin—bone cancer	8.73e-05	0.000485	CcSEcCtD
Mycophenolate mofetil—Urethral disorder—Doxorubicin—bone cancer	8.73e-05	0.000485	CcSEcCtD
Mycophenolate mofetil—Mediastinal disorder—Epirubicin—bone cancer	8.68e-05	0.000482	CcSEcCtD
Mycophenolate mofetil—Back pain—Methotrexate—bone cancer	8.66e-05	0.000481	CcSEcCtD
Mycophenolate mofetil—UGT2B7—Metabolism—NDUFA12—bone cancer	8.66e-05	0.000911	CbGpPWpGaD
Mycophenolate mofetil—Chills—Epirubicin—bone cancer	8.64e-05	0.00048	CcSEcCtD
Mycophenolate mofetil—IMPDH1—Metabolism—DHFR—bone cancer	8.62e-05	0.000907	CbGpPWpGaD
Mycophenolate mofetil—Arrhythmia—Epirubicin—bone cancer	8.6e-05	0.000478	CcSEcCtD
Mycophenolate mofetil—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—bone cancer	8.58e-05	0.000903	CbGpPWpGaD
Mycophenolate mofetil—Visual impairment—Doxorubicin—bone cancer	8.58e-05	0.000477	CcSEcCtD
Mycophenolate mofetil—ABCG2—HIF-1-alpha transcription factor network—JUN—bone cancer	8.57e-05	0.000901	CbGpPWpGaD
Mycophenolate mofetil—Alopecia—Epirubicin—bone cancer	8.51e-05	0.000473	CcSEcCtD
Mycophenolate mofetil—Vomiting—Cisplatin—bone cancer	8.47e-05	0.00047	CcSEcCtD
Mycophenolate mofetil—Mental disorder—Epirubicin—bone cancer	8.43e-05	0.000469	CcSEcCtD
Mycophenolate mofetil—Rash—Cisplatin—bone cancer	8.4e-05	0.000466	CcSEcCtD
Mycophenolate mofetil—Dermatitis—Cisplatin—bone cancer	8.39e-05	0.000466	CcSEcCtD
Mycophenolate mofetil—Malnutrition—Epirubicin—bone cancer	8.38e-05	0.000466	CcSEcCtD
Mycophenolate mofetil—Eye disorder—Doxorubicin—bone cancer	8.32e-05	0.000462	CcSEcCtD
Mycophenolate mofetil—Ill-defined disorder—Methotrexate—bone cancer	8.31e-05	0.000462	CcSEcCtD
Mycophenolate mofetil—Tinnitus—Doxorubicin—bone cancer	8.31e-05	0.000461	CcSEcCtD
Mycophenolate mofetil—Anaemia—Methotrexate—bone cancer	8.28e-05	0.00046	CcSEcCtD
Mycophenolate mofetil—Cardiac disorder—Doxorubicin—bone cancer	8.27e-05	0.000459	CcSEcCtD
Mycophenolate mofetil—Flatulence—Epirubicin—bone cancer	8.26e-05	0.000459	CcSEcCtD
Mycophenolate mofetil—SLCO1B1—Transmembrane transport of small molecules—TUBB4B—bone cancer	8.25e-05	0.000868	CbGpPWpGaD
Mycophenolate mofetil—Tension—Epirubicin—bone cancer	8.22e-05	0.000457	CcSEcCtD
Mycophenolate mofetil—Dysgeusia—Epirubicin—bone cancer	8.21e-05	0.000456	CcSEcCtD
Mycophenolate mofetil—Nervousness—Epirubicin—bone cancer	8.14e-05	0.000452	CcSEcCtD
Mycophenolate mofetil—Back pain—Epirubicin—bone cancer	8.11e-05	0.00045	CcSEcCtD
Mycophenolate mofetil—Angiopathy—Doxorubicin—bone cancer	8.08e-05	0.000449	CcSEcCtD
Mycophenolate mofetil—Malaise—Methotrexate—bone cancer	8.08e-05	0.000449	CcSEcCtD
Mycophenolate mofetil—Muscle spasms—Epirubicin—bone cancer	8.06e-05	0.000448	CcSEcCtD
Mycophenolate mofetil—IMPDH1—Metabolism—GNA11—bone cancer	8.05e-05	0.000847	CbGpPWpGaD
Mycophenolate mofetil—Vertigo—Methotrexate—bone cancer	8.05e-05	0.000447	CcSEcCtD
Mycophenolate mofetil—Mediastinal disorder—Doxorubicin—bone cancer	8.03e-05	0.000446	CcSEcCtD
Mycophenolate mofetil—Leukopenia—Methotrexate—bone cancer	8.02e-05	0.000445	CcSEcCtD
Mycophenolate mofetil—Chills—Doxorubicin—bone cancer	7.99e-05	0.000444	CcSEcCtD
Mycophenolate mofetil—UGT1A7—Metabolism—CYP3A4—bone cancer	7.98e-05	0.00084	CbGpPWpGaD
Mycophenolate mofetil—Arrhythmia—Doxorubicin—bone cancer	7.96e-05	0.000442	CcSEcCtD
Mycophenolate mofetil—SLCO1B3—Metabolism—NT5C3A—bone cancer	7.96e-05	0.000837	CbGpPWpGaD
Mycophenolate mofetil—Nausea—Cisplatin—bone cancer	7.91e-05	0.000439	CcSEcCtD
Mycophenolate mofetil—UGT1A8—Metabolism—ENO2—bone cancer	7.9e-05	0.000831	CbGpPWpGaD
Mycophenolate mofetil—Alopecia—Doxorubicin—bone cancer	7.87e-05	0.000437	CcSEcCtD
Mycophenolate mofetil—Cough—Methotrexate—bone cancer	7.81e-05	0.000434	CcSEcCtD
Mycophenolate mofetil—Mental disorder—Doxorubicin—bone cancer	7.8e-05	0.000434	CcSEcCtD
Mycophenolate mofetil—Ill-defined disorder—Epirubicin—bone cancer	7.78e-05	0.000432	CcSEcCtD
Mycophenolate mofetil—Convulsion—Methotrexate—bone cancer	7.76e-05	0.000431	CcSEcCtD
Mycophenolate mofetil—Malnutrition—Doxorubicin—bone cancer	7.75e-05	0.000431	CcSEcCtD
Mycophenolate mofetil—Anaemia—Epirubicin—bone cancer	7.75e-05	0.00043	CcSEcCtD
Mycophenolate mofetil—Agitation—Epirubicin—bone cancer	7.7e-05	0.000428	CcSEcCtD
Mycophenolate mofetil—IMPDH2—Metabolism—GSTP1—bone cancer	7.66e-05	0.000806	CbGpPWpGaD
Mycophenolate mofetil—Flatulence—Doxorubicin—bone cancer	7.64e-05	0.000424	CcSEcCtD
Mycophenolate mofetil—ABCG2—Transmembrane transport of small molecules—TUBB4B—bone cancer	7.64e-05	0.000804	CbGpPWpGaD
Mycophenolate mofetil—Arthralgia—Methotrexate—bone cancer	7.62e-05	0.000424	CcSEcCtD
Mycophenolate mofetil—Myalgia—Methotrexate—bone cancer	7.62e-05	0.000424	CcSEcCtD
Mycophenolate mofetil—Chest pain—Methotrexate—bone cancer	7.62e-05	0.000424	CcSEcCtD
Mycophenolate mofetil—Tension—Doxorubicin—bone cancer	7.61e-05	0.000423	CcSEcCtD
Mycophenolate mofetil—Dysgeusia—Doxorubicin—bone cancer	7.59e-05	0.000422	CcSEcCtD
Mycophenolate mofetil—ABCC2—Transmembrane transport of small molecules—TUBB2A—bone cancer	7.58e-05	0.000798	CbGpPWpGaD
Mycophenolate mofetil—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—bone cancer	7.57e-05	0.000421	CcSEcCtD
Mycophenolate mofetil—Malaise—Epirubicin—bone cancer	7.56e-05	0.00042	CcSEcCtD
Mycophenolate mofetil—Discomfort—Methotrexate—bone cancer	7.53e-05	0.000418	CcSEcCtD
Mycophenolate mofetil—Nervousness—Doxorubicin—bone cancer	7.53e-05	0.000418	CcSEcCtD
Mycophenolate mofetil—Vertigo—Epirubicin—bone cancer	7.53e-05	0.000418	CcSEcCtD
Mycophenolate mofetil—Syncope—Epirubicin—bone cancer	7.52e-05	0.000417	CcSEcCtD
Mycophenolate mofetil—Leukopenia—Epirubicin—bone cancer	7.5e-05	0.000417	CcSEcCtD
Mycophenolate mofetil—Back pain—Doxorubicin—bone cancer	7.5e-05	0.000417	CcSEcCtD
Mycophenolate mofetil—Muscle spasms—Doxorubicin—bone cancer	7.46e-05	0.000414	CcSEcCtD
Mycophenolate mofetil—Palpitations—Epirubicin—bone cancer	7.41e-05	0.000411	CcSEcCtD
Mycophenolate mofetil—Confusional state—Methotrexate—bone cancer	7.37e-05	0.000409	CcSEcCtD
Mycophenolate mofetil—Loss of consciousness—Epirubicin—bone cancer	7.37e-05	0.000409	CcSEcCtD
Mycophenolate mofetil—CYP2C8—Arachidonic acid metabolism—PTGS2—bone cancer	7.36e-05	0.000775	CbGpPWpGaD
Mycophenolate mofetil—UGT1A8—Metabolism—DHFR—bone cancer	7.33e-05	0.000771	CbGpPWpGaD
Mycophenolate mofetil—Cough—Epirubicin—bone cancer	7.31e-05	0.000406	CcSEcCtD
Mycophenolate mofetil—Anaphylactic shock—Methotrexate—bone cancer	7.31e-05	0.000406	CcSEcCtD
Mycophenolate mofetil—IMPDH1—Metabolism—CYP3A4—bone cancer	7.3e-05	0.000768	CbGpPWpGaD
Mycophenolate mofetil—Convulsion—Epirubicin—bone cancer	7.26e-05	0.000403	CcSEcCtD
Mycophenolate mofetil—Infection—Methotrexate—bone cancer	7.26e-05	0.000403	CcSEcCtD
Mycophenolate mofetil—Hypertension—Epirubicin—bone cancer	7.24e-05	0.000402	CcSEcCtD
Mycophenolate mofetil—Ill-defined disorder—Doxorubicin—bone cancer	7.2e-05	0.0004	CcSEcCtD
Mycophenolate mofetil—UGT2B7—Metabolism—NT5C3A—bone cancer	7.18e-05	0.000755	CbGpPWpGaD
Mycophenolate mofetil—Nervous system disorder—Methotrexate—bone cancer	7.17e-05	0.000398	CcSEcCtD
Mycophenolate mofetil—Anaemia—Doxorubicin—bone cancer	7.17e-05	0.000398	CcSEcCtD
Mycophenolate mofetil—Thrombocytopenia—Methotrexate—bone cancer	7.16e-05	0.000398	CcSEcCtD
Mycophenolate mofetil—CYP3A5—Biological oxidations—CYP3A4—bone cancer	7.14e-05	0.000751	CbGpPWpGaD
Mycophenolate mofetil—Chest pain—Epirubicin—bone cancer	7.14e-05	0.000396	CcSEcCtD
Mycophenolate mofetil—Myalgia—Epirubicin—bone cancer	7.14e-05	0.000396	CcSEcCtD
Mycophenolate mofetil—Arthralgia—Epirubicin—bone cancer	7.14e-05	0.000396	CcSEcCtD
Mycophenolate mofetil—Agitation—Doxorubicin—bone cancer	7.13e-05	0.000396	CcSEcCtD
Mycophenolate mofetil—SLCO1B1—Transmembrane transport of small molecules—TUBB2A—bone cancer	7.12e-05	0.000749	CbGpPWpGaD
Mycophenolate mofetil—Anxiety—Epirubicin—bone cancer	7.11e-05	0.000395	CcSEcCtD
Mycophenolate mofetil—Skin disorder—Methotrexate—bone cancer	7.1e-05	0.000394	CcSEcCtD
Mycophenolate mofetil—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—bone cancer	7.09e-05	0.000394	CcSEcCtD
Mycophenolate mofetil—Hyperhidrosis—Methotrexate—bone cancer	7.07e-05	0.000392	CcSEcCtD
Mycophenolate mofetil—Discomfort—Epirubicin—bone cancer	7.05e-05	0.000392	CcSEcCtD
Mycophenolate mofetil—CYP3A5—Metapathway biotransformation—CYP3A4—bone cancer	7.04e-05	0.000741	CbGpPWpGaD
Mycophenolate mofetil—UGT1A1—Metabolism—NDUFA12—bone cancer	7.04e-05	0.000741	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism—NDUFA12—bone cancer	7.04e-05	0.000741	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—bone cancer	7.03e-05	0.000739	CbGpPWpGaD
Mycophenolate mofetil—Malaise—Doxorubicin—bone cancer	6.99e-05	0.000388	CcSEcCtD
Mycophenolate mofetil—Dry mouth—Epirubicin—bone cancer	6.98e-05	0.000388	CcSEcCtD
Mycophenolate mofetil—Vertigo—Doxorubicin—bone cancer	6.97e-05	0.000387	CcSEcCtD
Mycophenolate mofetil—Anorexia—Methotrexate—bone cancer	6.97e-05	0.000387	CcSEcCtD
Mycophenolate mofetil—Syncope—Doxorubicin—bone cancer	6.95e-05	0.000386	CcSEcCtD
Mycophenolate mofetil—Leukopenia—Doxorubicin—bone cancer	6.94e-05	0.000386	CcSEcCtD
Mycophenolate mofetil—Confusional state—Epirubicin—bone cancer	6.9e-05	0.000383	CcSEcCtD
Mycophenolate mofetil—Palpitations—Doxorubicin—bone cancer	6.85e-05	0.000381	CcSEcCtD
Mycophenolate mofetil—UGT1A8—Metabolism—GNA11—bone cancer	6.85e-05	0.00072	CbGpPWpGaD
Mycophenolate mofetil—Oedema—Epirubicin—bone cancer	6.84e-05	0.00038	CcSEcCtD
Mycophenolate mofetil—Anaphylactic shock—Epirubicin—bone cancer	6.84e-05	0.00038	CcSEcCtD
Mycophenolate mofetil—Hypotension—Methotrexate—bone cancer	6.83e-05	0.000379	CcSEcCtD
Mycophenolate mofetil—UGT1A7—Metabolism—GSTP1—bone cancer	6.83e-05	0.000718	CbGpPWpGaD
Mycophenolate mofetil—Loss of consciousness—Doxorubicin—bone cancer	6.82e-05	0.000379	CcSEcCtD
Mycophenolate mofetil—Infection—Epirubicin—bone cancer	6.8e-05	0.000377	CcSEcCtD
Mycophenolate mofetil—Cough—Doxorubicin—bone cancer	6.77e-05	0.000376	CcSEcCtD
Mycophenolate mofetil—Shock—Epirubicin—bone cancer	6.73e-05	0.000374	CcSEcCtD
Mycophenolate mofetil—Convulsion—Doxorubicin—bone cancer	6.72e-05	0.000373	CcSEcCtD
Mycophenolate mofetil—Nervous system disorder—Epirubicin—bone cancer	6.71e-05	0.000373	CcSEcCtD
Mycophenolate mofetil—Thrombocytopenia—Epirubicin—bone cancer	6.7e-05	0.000372	CcSEcCtD
Mycophenolate mofetil—Hypertension—Doxorubicin—bone cancer	6.7e-05	0.000372	CcSEcCtD
Mycophenolate mofetil—Tachycardia—Epirubicin—bone cancer	6.68e-05	0.000371	CcSEcCtD
Mycophenolate mofetil—Musculoskeletal discomfort—Methotrexate—bone cancer	6.66e-05	0.00037	CcSEcCtD
Mycophenolate mofetil—Skin disorder—Epirubicin—bone cancer	6.64e-05	0.000369	CcSEcCtD
Mycophenolate mofetil—Hyperhidrosis—Epirubicin—bone cancer	6.61e-05	0.000367	CcSEcCtD
Mycophenolate mofetil—Insomnia—Methotrexate—bone cancer	6.61e-05	0.000367	CcSEcCtD
Mycophenolate mofetil—Myalgia—Doxorubicin—bone cancer	6.6e-05	0.000367	CcSEcCtD
Mycophenolate mofetil—Chest pain—Doxorubicin—bone cancer	6.6e-05	0.000367	CcSEcCtD
Mycophenolate mofetil—Arthralgia—Doxorubicin—bone cancer	6.6e-05	0.000367	CcSEcCtD
Mycophenolate mofetil—ABCG2—Transmembrane transport of small molecules—TUBB2A—bone cancer	6.59e-05	0.000694	CbGpPWpGaD
Mycophenolate mofetil—Anxiety—Doxorubicin—bone cancer	6.58e-05	0.000365	CcSEcCtD
Mycophenolate mofetil—Paraesthesia—Methotrexate—bone cancer	6.56e-05	0.000365	CcSEcCtD
Mycophenolate mofetil—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—bone cancer	6.56e-05	0.000364	CcSEcCtD
Mycophenolate mofetil—Discomfort—Doxorubicin—bone cancer	6.52e-05	0.000362	CcSEcCtD
Mycophenolate mofetil—Anorexia—Epirubicin—bone cancer	6.52e-05	0.000362	CcSEcCtD
Mycophenolate mofetil—Dyspnoea—Methotrexate—bone cancer	6.52e-05	0.000362	CcSEcCtD
Mycophenolate mofetil—Somnolence—Methotrexate—bone cancer	6.5e-05	0.000361	CcSEcCtD
Mycophenolate mofetil—Dry mouth—Doxorubicin—bone cancer	6.46e-05	0.000359	CcSEcCtD
Mycophenolate mofetil—SLCO1B1—Metabolism—NDUFA12—bone cancer	6.45e-05	0.000679	CbGpPWpGaD
Mycophenolate mofetil—Dyspepsia—Methotrexate—bone cancer	6.43e-05	0.000357	CcSEcCtD
Mycophenolate mofetil—Hypotension—Epirubicin—bone cancer	6.39e-05	0.000355	CcSEcCtD
Mycophenolate mofetil—Confusional state—Doxorubicin—bone cancer	6.38e-05	0.000354	CcSEcCtD
Mycophenolate mofetil—Decreased appetite—Methotrexate—bone cancer	6.35e-05	0.000353	CcSEcCtD
Mycophenolate mofetil—Anaphylactic shock—Doxorubicin—bone cancer	6.33e-05	0.000352	CcSEcCtD
Mycophenolate mofetil—Oedema—Doxorubicin—bone cancer	6.33e-05	0.000352	CcSEcCtD
Mycophenolate mofetil—Gastrointestinal disorder—Methotrexate—bone cancer	6.31e-05	0.000351	CcSEcCtD
Mycophenolate mofetil—Infection—Doxorubicin—bone cancer	6.29e-05	0.000349	CcSEcCtD
Mycophenolate mofetil—Pain—Methotrexate—bone cancer	6.25e-05	0.000347	CcSEcCtD
Mycophenolate mofetil—IMPDH1—Metabolism—GSTP1—bone cancer	6.24e-05	0.000657	CbGpPWpGaD
Mycophenolate mofetil—Musculoskeletal discomfort—Epirubicin—bone cancer	6.23e-05	0.000346	CcSEcCtD
Mycophenolate mofetil—Shock—Doxorubicin—bone cancer	6.23e-05	0.000346	CcSEcCtD
Mycophenolate mofetil—UGT1A8—Metabolism—CYP3A4—bone cancer	6.21e-05	0.000653	CbGpPWpGaD
Mycophenolate mofetil—Nervous system disorder—Doxorubicin—bone cancer	6.21e-05	0.000345	CcSEcCtD
Mycophenolate mofetil—Thrombocytopenia—Doxorubicin—bone cancer	6.2e-05	0.000344	CcSEcCtD
Mycophenolate mofetil—Insomnia—Epirubicin—bone cancer	6.19e-05	0.000344	CcSEcCtD
Mycophenolate mofetil—CYP2C8—Biological oxidations—CYP3A4—bone cancer	6.18e-05	0.000651	CbGpPWpGaD
Mycophenolate mofetil—Tachycardia—Doxorubicin—bone cancer	6.18e-05	0.000343	CcSEcCtD
Mycophenolate mofetil—Skin disorder—Doxorubicin—bone cancer	6.15e-05	0.000341	CcSEcCtD
Mycophenolate mofetil—Paraesthesia—Epirubicin—bone cancer	6.14e-05	0.000341	CcSEcCtD
Mycophenolate mofetil—Hyperhidrosis—Doxorubicin—bone cancer	6.12e-05	0.00034	CcSEcCtD
Mycophenolate mofetil—CYP3A5—Biological oxidations—GSTP1—bone cancer	6.11e-05	0.000642	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metapathway biotransformation—CYP3A4—bone cancer	6.1e-05	0.000642	CbGpPWpGaD
Mycophenolate mofetil—Dyspnoea—Epirubicin—bone cancer	6.1e-05	0.000339	CcSEcCtD
Mycophenolate mofetil—Somnolence—Epirubicin—bone cancer	6.08e-05	0.000338	CcSEcCtD
Mycophenolate mofetil—ALB—Platelet activation, signaling and aggregation—SPARC—bone cancer	6.07e-05	0.000638	CbGpPWpGaD
Mycophenolate mofetil—Anorexia—Doxorubicin—bone cancer	6.03e-05	0.000335	CcSEcCtD
Mycophenolate mofetil—Feeling abnormal—Methotrexate—bone cancer	6.02e-05	0.000335	CcSEcCtD
Mycophenolate mofetil—CYP3A5—Metapathway biotransformation—GSTP1—bone cancer	6.02e-05	0.000634	CbGpPWpGaD
Mycophenolate mofetil—Dyspepsia—Epirubicin—bone cancer	6.02e-05	0.000334	CcSEcCtD
Mycophenolate mofetil—Gastrointestinal pain—Methotrexate—bone cancer	5.98e-05	0.000332	CcSEcCtD
Mycophenolate mofetil—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—bone cancer	5.97e-05	0.000629	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—NDUFA12—bone cancer	5.97e-05	0.000628	CbGpPWpGaD
Mycophenolate mofetil—Decreased appetite—Epirubicin—bone cancer	5.95e-05	0.00033	CcSEcCtD
Mycophenolate mofetil—Hypotension—Doxorubicin—bone cancer	5.91e-05	0.000328	CcSEcCtD
Mycophenolate mofetil—Gastrointestinal disorder—Epirubicin—bone cancer	5.91e-05	0.000328	CcSEcCtD
Mycophenolate mofetil—Pain—Epirubicin—bone cancer	5.85e-05	0.000325	CcSEcCtD
Mycophenolate mofetil—Constipation—Epirubicin—bone cancer	5.85e-05	0.000325	CcSEcCtD
Mycophenolate mofetil—UGT1A1—Metabolism—NT5C3A—bone cancer	5.83e-05	0.000614	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism—NT5C3A—bone cancer	5.83e-05	0.000614	CbGpPWpGaD
Mycophenolate mofetil—Urticaria—Methotrexate—bone cancer	5.81e-05	0.000323	CcSEcCtD
Mycophenolate mofetil—Abdominal pain—Methotrexate—bone cancer	5.78e-05	0.000321	CcSEcCtD
Mycophenolate mofetil—Body temperature increased—Methotrexate—bone cancer	5.78e-05	0.000321	CcSEcCtD
Mycophenolate mofetil—Musculoskeletal discomfort—Doxorubicin—bone cancer	5.77e-05	0.00032	CcSEcCtD
Mycophenolate mofetil—UGT1A6—Metabolism—ENO2—bone cancer	5.76e-05	0.000606	CbGpPWpGaD
Mycophenolate mofetil—Insomnia—Doxorubicin—bone cancer	5.72e-05	0.000318	CcSEcCtD
Mycophenolate mofetil—Paraesthesia—Doxorubicin—bone cancer	5.68e-05	0.000316	CcSEcCtD
Mycophenolate mofetil—Dyspnoea—Doxorubicin—bone cancer	5.64e-05	0.000313	CcSEcCtD
Mycophenolate mofetil—Feeling abnormal—Epirubicin—bone cancer	5.64e-05	0.000313	CcSEcCtD
Mycophenolate mofetil—Somnolence—Doxorubicin—bone cancer	5.63e-05	0.000313	CcSEcCtD
Mycophenolate mofetil—Gastrointestinal pain—Epirubicin—bone cancer	5.59e-05	0.000311	CcSEcCtD
Mycophenolate mofetil—Dyspepsia—Doxorubicin—bone cancer	5.57e-05	0.000309	CcSEcCtD
Mycophenolate mofetil—ALB—Platelet activation, signaling and aggregation—GNA11—bone cancer	5.55e-05	0.000584	CbGpPWpGaD
Mycophenolate mofetil—Decreased appetite—Doxorubicin—bone cancer	5.5e-05	0.000306	CcSEcCtD
Mycophenolate mofetil—Gastrointestinal disorder—Doxorubicin—bone cancer	5.46e-05	0.000304	CcSEcCtD
Mycophenolate mofetil—ABCB1—Integrated Pancreatic Cancer Pathway—EZH2—bone cancer	5.44e-05	0.000572	CbGpPWpGaD
Mycophenolate mofetil—Urticaria—Epirubicin—bone cancer	5.43e-05	0.000302	CcSEcCtD
Mycophenolate mofetil—Pain—Doxorubicin—bone cancer	5.41e-05	0.000301	CcSEcCtD
Mycophenolate mofetil—Constipation—Doxorubicin—bone cancer	5.41e-05	0.000301	CcSEcCtD
Mycophenolate mofetil—Abdominal pain—Epirubicin—bone cancer	5.41e-05	0.0003	CcSEcCtD
Mycophenolate mofetil—Body temperature increased—Epirubicin—bone cancer	5.41e-05	0.0003	CcSEcCtD
Mycophenolate mofetil—Hypersensitivity—Methotrexate—bone cancer	5.38e-05	0.000299	CcSEcCtD
Mycophenolate mofetil—UGT1A6—Metabolism—DHFR—bone cancer	5.34e-05	0.000562	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—NT5C3A—bone cancer	5.34e-05	0.000562	CbGpPWpGaD
Mycophenolate mofetil—UGT1A8—Metabolism—GSTP1—bone cancer	5.31e-05	0.000559	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Biological oxidations—GSTP1—bone cancer	5.29e-05	0.000556	CbGpPWpGaD
Mycophenolate mofetil—Asthenia—Methotrexate—bone cancer	5.24e-05	0.000291	CcSEcCtD
Mycophenolate mofetil—CYP2C8—Metapathway biotransformation—GSTP1—bone cancer	5.22e-05	0.000549	CbGpPWpGaD
Mycophenolate mofetil—Feeling abnormal—Doxorubicin—bone cancer	5.22e-05	0.00029	CcSEcCtD
Mycophenolate mofetil—Gastrointestinal pain—Doxorubicin—bone cancer	5.18e-05	0.000287	CcSEcCtD
Mycophenolate mofetil—Pruritus—Methotrexate—bone cancer	5.17e-05	0.000287	CcSEcCtD
Mycophenolate mofetil—Hypersensitivity—Epirubicin—bone cancer	5.04e-05	0.00028	CcSEcCtD
Mycophenolate mofetil—ALB—Platelet activation, signaling and aggregation—IL3—bone cancer	5.03e-05	0.000529	CbGpPWpGaD
Mycophenolate mofetil—Urticaria—Doxorubicin—bone cancer	5.03e-05	0.000279	CcSEcCtD
Mycophenolate mofetil—Body temperature increased—Doxorubicin—bone cancer	5e-05	0.000278	CcSEcCtD
Mycophenolate mofetil—Abdominal pain—Doxorubicin—bone cancer	5e-05	0.000278	CcSEcCtD
Mycophenolate mofetil—Diarrhoea—Methotrexate—bone cancer	5e-05	0.000278	CcSEcCtD
Mycophenolate mofetil—UGT1A6—Metabolism—GNA11—bone cancer	5e-05	0.000526	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Integrated Pancreatic Cancer Pathway—IL3—bone cancer	4.95e-05	0.000521	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—NT5C3A—bone cancer	4.95e-05	0.000521	CbGpPWpGaD
Mycophenolate mofetil—Asthenia—Epirubicin—bone cancer	4.91e-05	0.000273	CcSEcCtD
Mycophenolate mofetil—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—bone cancer	4.89e-05	0.000514	CbGpPWpGaD
Mycophenolate mofetil—Pruritus—Epirubicin—bone cancer	4.84e-05	0.000269	CcSEcCtD
Mycophenolate mofetil—Dizziness—Methotrexate—bone cancer	4.83e-05	0.000268	CcSEcCtD
Mycophenolate mofetil—ALB—Transmembrane transport of small molecules—TUBB4B—bone cancer	4.71e-05	0.000496	CbGpPWpGaD
Mycophenolate mofetil—Diarrhoea—Epirubicin—bone cancer	4.68e-05	0.00026	CcSEcCtD
Mycophenolate mofetil—Hypersensitivity—Doxorubicin—bone cancer	4.66e-05	0.000259	CcSEcCtD
Mycophenolate mofetil—ALB—Selenium Micronutrient Network—PTGS2—bone cancer	4.66e-05	0.00049	CbGpPWpGaD
Mycophenolate mofetil—Vomiting—Methotrexate—bone cancer	4.65e-05	0.000258	CcSEcCtD
Mycophenolate mofetil—ABCB1—HIF-1-alpha transcription factor network—JUN—bone cancer	4.63e-05	0.000487	CbGpPWpGaD
Mycophenolate mofetil—Rash—Methotrexate—bone cancer	4.61e-05	0.000256	CcSEcCtD
Mycophenolate mofetil—Dermatitis—Methotrexate—bone cancer	4.6e-05	0.000256	CcSEcCtD
Mycophenolate mofetil—Headache—Methotrexate—bone cancer	4.58e-05	0.000254	CcSEcCtD
Mycophenolate mofetil—Asthenia—Doxorubicin—bone cancer	4.54e-05	0.000252	CcSEcCtD
Mycophenolate mofetil—UGT1A6—Metabolism—CYP3A4—bone cancer	4.53e-05	0.000476	CbGpPWpGaD
Mycophenolate mofetil—Dizziness—Epirubicin—bone cancer	4.52e-05	0.000251	CcSEcCtD
Mycophenolate mofetil—Pruritus—Doxorubicin—bone cancer	4.48e-05	0.000249	CcSEcCtD
Mycophenolate mofetil—CYP3A4—Tryptophan metabolism—MDM2—bone cancer	4.38e-05	0.000461	CbGpPWpGaD
Mycophenolate mofetil—Vomiting—Epirubicin—bone cancer	4.35e-05	0.000242	CcSEcCtD
Mycophenolate mofetil—Nausea—Methotrexate—bone cancer	4.34e-05	0.000241	CcSEcCtD
Mycophenolate mofetil—Diarrhoea—Doxorubicin—bone cancer	4.33e-05	0.000241	CcSEcCtD
Mycophenolate mofetil—Rash—Epirubicin—bone cancer	4.31e-05	0.00024	CcSEcCtD
Mycophenolate mofetil—Dermatitis—Epirubicin—bone cancer	4.31e-05	0.000239	CcSEcCtD
Mycophenolate mofetil—Headache—Epirubicin—bone cancer	4.29e-05	0.000238	CcSEcCtD
Mycophenolate mofetil—CYP3A5—Metabolism—NDUFA12—bone cancer	4.28e-05	0.00045	CbGpPWpGaD
Mycophenolate mofetil—Dizziness—Doxorubicin—bone cancer	4.19e-05	0.000232	CcSEcCtD
Mycophenolate mofetil—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—bone cancer	4.14e-05	0.000436	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Transmembrane transport of small molecules—TUBB4B—bone cancer	4.13e-05	0.000435	CbGpPWpGaD
Mycophenolate mofetil—ALB—Transmembrane transport of small molecules—TUBB2A—bone cancer	4.07e-05	0.000428	CbGpPWpGaD
Mycophenolate mofetil—Nausea—Epirubicin—bone cancer	4.06e-05	0.000226	CcSEcCtD
Mycophenolate mofetil—Vomiting—Doxorubicin—bone cancer	4.02e-05	0.000224	CcSEcCtD
Mycophenolate mofetil—Rash—Doxorubicin—bone cancer	3.99e-05	0.000222	CcSEcCtD
Mycophenolate mofetil—Dermatitis—Doxorubicin—bone cancer	3.99e-05	0.000221	CcSEcCtD
Mycophenolate mofetil—IMPDH2—Metabolism—PTGS2—bone cancer	3.97e-05	0.000418	CbGpPWpGaD
Mycophenolate mofetil—Headache—Doxorubicin—bone cancer	3.96e-05	0.00022	CcSEcCtD
Mycophenolate mofetil—UGT1A6—Metabolism—GSTP1—bone cancer	3.87e-05	0.000408	CbGpPWpGaD
Mycophenolate mofetil—Nausea—Doxorubicin—bone cancer	3.76e-05	0.000209	CcSEcCtD
Mycophenolate mofetil—CYP2C8—Metabolism—NDUFA12—bone cancer	3.71e-05	0.00039	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—NDUFA12—bone cancer	3.69e-05	0.000388	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Transmembrane transport of small molecules—TUBB2A—bone cancer	3.57e-05	0.000375	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—NT5C3A—bone cancer	3.55e-05	0.000373	CbGpPWpGaD
Mycophenolate mofetil—UGT1A7—Metabolism—PTGS2—bone cancer	3.54e-05	0.000372	CbGpPWpGaD
Mycophenolate mofetil—ALB—Folate Metabolism—TP53—bone cancer	3.49e-05	0.000367	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B3—Metabolism—ENO2—bone cancer	3.48e-05	0.000367	CbGpPWpGaD
Mycophenolate mofetil—IMPDH1—Metabolism—PTGS2—bone cancer	3.23e-05	0.00034	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B3—Metabolism—DHFR—bone cancer	3.23e-05	0.00034	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—NDUFA12—bone cancer	3.23e-05	0.00034	CbGpPWpGaD
Mycophenolate mofetil—UGT2B7—Metabolism—ENO2—bone cancer	3.14e-05	0.000331	CbGpPWpGaD
Mycophenolate mofetil—ALB—Hemostasis—SPARC—bone cancer	3.13e-05	0.000329	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—bone cancer	3.07e-05	0.000323	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—NT5C3A—bone cancer	3.07e-05	0.000323	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—NT5C3A—bone cancer	3.05e-05	0.000321	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B3—Metabolism—GNA11—bone cancer	3.02e-05	0.000318	CbGpPWpGaD
Mycophenolate mofetil—UGT2B7—Metabolism—DHFR—bone cancer	2.92e-05	0.000307	CbGpPWpGaD
Mycophenolate mofetil—ALB—Hemostasis—GNA11—bone cancer	2.86e-05	0.000301	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Biological oxidations—GSTP1—bone cancer	2.84e-05	0.000299	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metapathway biotransformation—GSTP1—bone cancer	2.8e-05	0.000295	CbGpPWpGaD
Mycophenolate mofetil—UGT1A8—Metabolism—PTGS2—bone cancer	2.75e-05	0.000289	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B3—Metabolism—CYP3A4—bone cancer	2.74e-05	0.000288	CbGpPWpGaD
Mycophenolate mofetil—UGT2B7—Metabolism—GNA11—bone cancer	2.73e-05	0.000287	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B3—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	2.73e-05	0.000287	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—NT5C3A—bone cancer	2.68e-05	0.000282	CbGpPWpGaD
Mycophenolate mofetil—ALB—Hemostasis—IL3—bone cancer	2.59e-05	0.000273	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism—ENO2—bone cancer	2.55e-05	0.000269	CbGpPWpGaD
Mycophenolate mofetil—UGT1A1—Metabolism—ENO2—bone cancer	2.55e-05	0.000269	CbGpPWpGaD
Mycophenolate mofetil—UGT2B7—Metabolism—CYP3A4—bone cancer	2.47e-05	0.00026	CbGpPWpGaD
Mycophenolate mofetil—UGT1A1—Metabolism—DHFR—bone cancer	2.37e-05	0.000249	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism—DHFR—bone cancer	2.37e-05	0.000249	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B3—Metabolism—GSTP1—bone cancer	2.34e-05	0.000246	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—ENO2—bone cancer	2.34e-05	0.000246	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—bone cancer	2.28e-05	0.00024	CbGpPWpGaD
Mycophenolate mofetil—UGT1A1—Metabolism—GNA11—bone cancer	2.22e-05	0.000233	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism—GNA11—bone cancer	2.22e-05	0.000233	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—bone cancer	2.2e-05	0.000231	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—DHFR—bone cancer	2.17e-05	0.000229	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—ENO2—bone cancer	2.17e-05	0.000228	CbGpPWpGaD
Mycophenolate mofetil—UGT2B7—Metabolism—GSTP1—bone cancer	2.11e-05	0.000222	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—GNA11—bone cancer	2.03e-05	0.000214	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—DHFR—bone cancer	2.01e-05	0.000212	CbGpPWpGaD
Mycophenolate mofetil—UGT1A1—Metabolism—CYP3A4—bone cancer	2.01e-05	0.000211	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism—CYP3A4—bone cancer	2.01e-05	0.000211	CbGpPWpGaD
Mycophenolate mofetil—UGT1A6—Metabolism—PTGS2—bone cancer	2.01e-05	0.000211	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	2e-05	0.00021	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—NDUFA12—bone cancer	1.99e-05	0.000209	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—bone cancer	1.98e-05	0.000208	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—GNA11—bone cancer	1.88e-05	0.000198	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—CYP3A4—bone cancer	1.84e-05	0.000194	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.83e-05	0.000193	CbGpPWpGaD
Mycophenolate mofetil—UGT1A1—Metabolism—GSTP1—bone cancer	1.72e-05	0.000181	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism—GSTP1—bone cancer	1.72e-05	0.000181	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—CYP3A4—bone cancer	1.7e-05	0.000179	CbGpPWpGaD
Mycophenolate mofetil—ALB—Hemostasis—PLAU—bone cancer	1.7e-05	0.000179	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—NT5C3A—bone cancer	1.65e-05	0.000173	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—GSTP1—bone cancer	1.57e-05	0.000166	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	1.56e-05	0.000164	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—ENO2—bone cancer	1.55e-05	0.000163	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—GSTP1—bone cancer	1.46e-05	0.000153	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—DHFR—bone cancer	1.44e-05	0.000152	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—GNA11—bone cancer	1.35e-05	0.000142	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—ENO2—bone cancer	1.35e-05	0.000142	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—ENO2—bone cancer	1.34e-05	0.000141	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	1.31e-05	0.000137	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—DHFR—bone cancer	1.25e-05	0.000131	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—DHFR—bone cancer	1.24e-05	0.000131	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—CYP3A4—bone cancer	1.22e-05	0.000128	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B3—Metabolism—PTGS2—bone cancer	1.21e-05	0.000128	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—ENO2—bone cancer	1.17e-05	0.000123	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—GNA11—bone cancer	1.17e-05	0.000123	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—GNA11—bone cancer	1.16e-05	0.000122	CbGpPWpGaD
Mycophenolate mofetil—UGT2B7—Metabolism—PTGS2—bone cancer	1.1e-05	0.000115	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—DHFR—bone cancer	1.09e-05	0.000114	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—CYP3A4—bone cancer	1.06e-05	0.000111	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.05e-05	0.000111	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—CYP3A4—bone cancer	1.05e-05	0.000111	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.05e-05	0.00011	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—GSTP1—bone cancer	1.04e-05	0.00011	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—GNA11—bone cancer	1.02e-05	0.000107	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—CYP3A4—bone cancer	9.21e-06	9.69e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—GSTP1—bone cancer	9.04e-06	9.52e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—GSTP1—bone cancer	8.99e-06	9.46e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A1—Metabolism—PTGS2—bone cancer	8.9e-06	9.36e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism—PTGS2—bone cancer	8.9e-06	9.36e-05	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—PTGS2—bone cancer	8.15e-06	8.58e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—GSTP1—bone cancer	7.88e-06	8.29e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—PTGS2—bone cancer	7.55e-06	7.94e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—ENO2—bone cancer	7.22e-06	7.6e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Hemostasis—TP53—bone cancer	6.84e-06	7.2e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—DHFR—bone cancer	6.7e-06	7.05e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—GNA11—bone cancer	6.26e-06	6.59e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—PTGS2—bone cancer	5.41e-06	5.69e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—GSTP1—bone cancer	4.85e-06	5.11e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—PTGS2—bone cancer	4.69e-06	4.93e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—PTGS2—bone cancer	4.66e-06	4.9e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—PTGS2—bone cancer	4.08e-06	4.29e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—PTGS2—bone cancer	2.51e-06	2.65e-05	CbGpPWpGaD
